Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Novel transcript, antisense to HIP1R" (ENSG00000302017, LOC124903040) refers to a non-coding RNA annotated in the human genome, positioned antisense to the HIP1R protein-coding gene. There is currently no recognized biological function, disease association, drug interaction, or experimental characterization for this transcript. It is included in some variant annotations as a downstream gene locus but is not considered a canonical therapeutic target[2]. The term "novel transcript, antisense to HIP1R" merely describes its position and orientation in the genome relative to the HIP1R gene, without implying any protein product or recognized molecular activity. Note: If your interest is in the *HIP1R* gene itself, that gene encodes a well-characterized protein involved in membrane trafficking, actin cytoskeleton interactions, and possibly cell survival, and does have recognized molecular functions and some disease connections[1][7][9]. The transcript ENSG00000302017/LOC124903040 is distinct and should not be conflated with the HIP1R protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to Huntingtin-interacting protein 1-related protein (LOC124903040).